MedPath
TGA Approval

SYLVANT siltuximab (rmc) 400mg powder for injection vial (229997)

229997

SYLVANT siltuximab (rmc) 400mg powder for injection vial

Recordati Rare Diseases Australia Pty Ltd

August 31, 2015

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a68f16f859a77466a03c12270eff6005.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/be503226c051b88205cb23d04aefc2f6.pdf

Active Ingredients

siltuximab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SYLVANT siltuximab (rmc) 400mg powder for injection vial (229997) - TGA 批准文号 | MedPath